We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Potential role of embelin in the prevention of Freund's adjuvant induced inflammation and ROS.
- Authors
Kumaraswamy, H. M.; Krishna, V.; Sharath, R.; Satyanarayan, N. D.; Meghana, P.; Jain, R. Sandeep Kumar; Prashanth, N.; Raja Naika, H.
- Abstract
Inflammation is a complex biological response involving immune cells to an infection creating injury to the normal tissues. The anti-inflammatory efficacy of embelin, a benzoquinone from the plant Embelia ribes, was screened for antioxidant and anti-inflammatory activity in carrageenan and Freund's adjuvant-induced inflammation models. Embelin exhibited significant dose-dependent antioxidant potential. In carrageenan-induced inflammation, embelin (20 mg/kg) showed an inhibition of oedema by 71.01 ± 0.12% and 81.91 ± 0.67% in Freund's adjuvant-treated chronic inflammation model and resulted in a noticeable increase in adrenal size and restoration of the weight of spleen. Embelin also demonstrated cytoprotective effects on HEK-293 cells under induced oxidative stress. In silico analysis, embelin demonstrated binding energy of − 7.7 kcal/Mol and − 7.0 kcal/Mol with COX1 and COX2 with two hydrogen bonds. These results further prove that embelin could be a promising anti-inflammatory agent and supports the traditional use of Embelia ribes for rheumatism.
- Publication
3 Biotech, 2021, Vol 12, Issue 1, p1
- ISSN
2190-572X
- Publication type
Article
- DOI
10.1007/s13205-021-03071-5